Aati, S.; Farouk, H.O.; Elkarmalawy, M.H.; Aati, H.Y.; Tolba, N.S.; Hassan, H.M.; Rateb, M.E.; Hamad, D.S.
Intratracheal Administration of Itraconazole-Loaded Hyaluronated Glycerosomes as a Promising Nanoplatform for the Treatment of Lung Cancer: Formulation, Physiochemical, and In Vivo Distribution. Pharmaceutics 2024, 16, 1432.
https://doi.org/10.3390/pharmaceutics16111432
AMA Style
Aati S, Farouk HO, Elkarmalawy MH, Aati HY, Tolba NS, Hassan HM, Rateb ME, Hamad DS.
Intratracheal Administration of Itraconazole-Loaded Hyaluronated Glycerosomes as a Promising Nanoplatform for the Treatment of Lung Cancer: Formulation, Physiochemical, and In Vivo Distribution. Pharmaceutics. 2024; 16(11):1432.
https://doi.org/10.3390/pharmaceutics16111432
Chicago/Turabian Style
Aati, Sultan, Hanan O. Farouk, Marwa H. Elkarmalawy, Hanan Y. Aati, Nahla Sameh Tolba, Hossam M. Hassan, Mostafa E. Rateb, and Doaa S. Hamad.
2024. "Intratracheal Administration of Itraconazole-Loaded Hyaluronated Glycerosomes as a Promising Nanoplatform for the Treatment of Lung Cancer: Formulation, Physiochemical, and In Vivo Distribution" Pharmaceutics 16, no. 11: 1432.
https://doi.org/10.3390/pharmaceutics16111432
APA Style
Aati, S., Farouk, H. O., Elkarmalawy, M. H., Aati, H. Y., Tolba, N. S., Hassan, H. M., Rateb, M. E., & Hamad, D. S.
(2024). Intratracheal Administration of Itraconazole-Loaded Hyaluronated Glycerosomes as a Promising Nanoplatform for the Treatment of Lung Cancer: Formulation, Physiochemical, and In Vivo Distribution. Pharmaceutics, 16(11), 1432.
https://doi.org/10.3390/pharmaceutics16111432
